These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1902262)

  • 1. Interaction between Pseudomonas aeruginosa and Staphylococcus aureus: description of an anti-staphylococcal substance.
    Machan ZA; Pitt TL; White W; Watson D; Taylor GW; Cole PJ; Wilson R
    J Med Microbiol; 1991 Apr; 34(4):213-7. PubMed ID: 1902262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Growth inhibitory activity of clinical isolates of Pseudomonas aeruginosa against Staphylococcus aureus (MRSA and MSSA)].
    Ogino J; Yamada T; Goto R; Kikushima K; Fujimori I
    Kansenshogaku Zasshi; 1992 Jul; 66(7):909-13. PubMed ID: 1431366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofilm-forming capacity of Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa from ocular infections.
    Hou W; Sun X; Wang Z; Zhang Y
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5624-31. PubMed ID: 22736609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coculture of Staphylococcus aureus with Pseudomonas aeruginosa Drives S. aureus towards Fermentative Metabolism and Reduced Viability in a Cystic Fibrosis Model.
    Filkins LM; Graber JA; Olson DG; Dolben EL; Lynd LR; Bhuju S; O'Toole GA
    J Bacteriol; 2015 Jul; 197(14):2252-64. PubMed ID: 25917910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients.
    Vergison A; Denis O; Deplano A; Casimir G; Claeys G; DeBaets F; DeBoeck K; Douat N; Franckx H; Gigi J; Ieven M; Knoop C; Lebeque P; Lebrun F; Malfroot A; Paucquay F; Pierard D; Van Eldere J; Struelens MJ
    J Antimicrob Chemother; 2007 May; 59(5):893-9. PubMed ID: 17341469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiologic and therapeutic aspects of Staphylococcus aureus in cystic fibrosis patients.
    Bauernfeind A; Hörl G; Przyklenk B
    Scand J Gastroenterol Suppl; 1988; 143():99-102. PubMed ID: 3164518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Gram stain of sputa from cystic fibrosis patients to predict the presence of Staphylococcus aureus.
    Perez LR; Dias CA
    Diagn Microbiol Infect Dis; 2013 Oct; 77(2):99-100. PubMed ID: 23886792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of Staphylococcus aureus from sputum in cystic fibrosis.
    Sparham PD; Lobban DI; Speller DC
    J Clin Pathol; 1978 Oct; 31(10):913-8. PubMed ID: 101553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum.
    Palmer KL; Aye LM; Whiteley M
    J Bacteriol; 2007 Nov; 189(22):8079-87. PubMed ID: 17873029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis.
    Mainz JG; Naehrlich L; Schien M; Käding M; Schiller I; Mayr S; Schneider G; Wiedemann B; Wiehlmann L; Cramer N; Pfister W; Kahl BC; Beck JF; Tümmler B
    Thorax; 2009 Jun; 64(6):535-40. PubMed ID: 19282318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of erythromycin on anti staphylococcal activity and dye production of Pseudomonas aeruginosa isolated from clinical materials].
    Ogino J; Yamada T; Kozeni T; Ito M; Kikushima K; Goto R; Fujimori I; Hisamatsu K; Murakami Y
    Kansenshogaku Zasshi; 1993 Jan; 67(1):18-23. PubMed ID: 8450271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR; Pressler T; Hoiby N; Johansen HK
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa.
    Tam VH; Kabbara S; Vo G; Schilling AN; Coyle EA
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2626-31. PubMed ID: 16870751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antimicrobial efficacy of riboflavin and ultraviolet light on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa.
    Schrier A; Greebel G; Attia H; Trokel S; Smith EF
    J Refract Surg; 2009 Sep; 25(9):S799-802. PubMed ID: 19772254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro production of biofilm in a flow cell system in a strain of Pseudomonas aeruginosa and Staphylococcus aureus and determination of efficiency of ciprofloxacin against them.
    Gupta S; Agarwal S; Sahoo DR; Muralidharan S
    Indian J Pathol Microbiol; 2011; 54(3):569-71. PubMed ID: 21934223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus alters growth activity, autolysis, and antibiotic tolerance in a human host-adapted Pseudomonas aeruginosa lineage.
    Michelsen CF; Christensen AM; Bojer MS; Høiby N; Ingmer H; Jelsbak L
    J Bacteriol; 2014 Nov; 196(22):3903-11. PubMed ID: 25182495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective media for the quantitation of bacteria in cystic fibrosis sputum.
    Wong K; Roberts MC; Owens L; Fife M; Smith AL
    J Med Microbiol; 1984 Apr; 17(2):113-9. PubMed ID: 6423825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity.
    Pernet E; Guillemot L; Burgel PR; Martin C; Lambeau G; Sermet-Gaudelus I; Sands D; Leduc D; Morand PC; Jeammet L; Chignard M; Wu Y; Touqui L
    Nat Commun; 2014 Oct; 5():5105. PubMed ID: 25290234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients.
    Sajjan US; Tran LT; Sole N; Rovaldi C; Akiyama A; Friden PM; Forstner JF; Rothstein DM
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3437-44. PubMed ID: 11709321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis.
    Kerr J
    J Infect; 1994 May; 28(3):305-10. PubMed ID: 7522262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.